Molecular mechanism of recombinant liver fatty acid binding protein's antioxidant activity.
about
A disulfide bridge allows for site-selective binding in liver bile acid binding protein thereby stabilising the orientation of key amino acid side chainsRecent insights into the biological functions of liver fatty acid binding protein 1Fluorescent n-3 and n-6 very long chain polyunsaturated fatty acids: three-photon imaging in living cells expressing liver fatty acid-binding proteinStructural and functional interaction of fatty acids with human liver fatty acid-binding protein (L-FABP) T94A variantFatty Acid Binding Protein-1 (FABP1) and the Human FABP1 T94A Variant: Roles in the Endocannabinoid System and Dyslipidemias.Silencing of FABP1 ameliorates hepatic steatosis, inflammation, and oxidative stress in mice with nonalcoholic fatty liver disease.Comparative study of the fatty acid binding process of a new FABP from Cherax quadricarinatus by fluorescence intensity, lifetime and anisotropy.Ablating L-FABP in SCP-2/SCP-x null mice impairs bile acid metabolism and biliary HDL-cholesterol secretion.Epidermal fatty acid-binding protein protects nerve growth factor-differentiated PC12 cells from lipotoxic injuryHepatoprotective role of liver fatty acid binding protein in acetaminophen induced toxicity.Human FABP1 T94A variant enhances cholesterol uptakeThe effect of cocoa supplementation on hepatic steatosis, reactive oxygen species and LFABP in a rat model of NASHLoss of L-FABP, SCP-2/SCP-x, or both induces hepatic lipid accumulation in female miceLoss of intracellular lipid binding proteins differentially impacts saturated fatty acid uptake and nuclear targeting in mouse hepatocytesSusceptibility of L-FABP-/- mice to oxidative stress in early-stage alcoholic liver.Liver fatty acid-binding protein (L-FABP) promotes cellular angiogenesis and migration in hepatocellular carcinoma.Fatty acid-binding protein 1 is preferentially lost in microsatellite instable colorectal carcinomas and is immune modulated via the interferon γ pathway.Modulation of fatty acid transport and metabolism by maternal obesity in the human full-term placenta.Salivary and serum biomarkers for the study of side effects of aripiprazole coprescribed with mirtazapine in rats.Cytoprotective role of the fatty acid binding protein 4 against oxidative and endoplasmic reticulum stress in 3T3-L1 adipocytes.Role of bardoxolone methyl, a nuclear factor erythroid 2-related factor 2 activator, in aldosterone- and salt-induced renal injury.Oxidative stress-mediated developmental toxicity induced by isoniazide in zebrafish embryos and larvae.Renoprotective effect of renal liver-type fatty acid binding protein and angiotensin II type 1a receptor loss in renal injury caused by RAS activation.Urinary protein biomarkers of kidney injury in patients receiving cisplatin chemotherapy.Cold stress initiates the Nrf2/UGT1A1/L-FABP signaling pathway in chickens.Ameliorative effect of naringin in acetaminophen-induced hepatic and renal toxicity in laboratory rats: role of FXR and KIM-1.Human liver-type fatty acid-binding protein protects against tubulointerstitial injury in aldosterone-induced renal injury.
P2860
Q27677009-E4CFC06D-5DB0-4FA4-8B71-BC91126AD98AQ28268205-2709D262-D35C-41DF-92D4-AEF88DEB8E5CQ33552039-36E9531F-BB80-4A56-8AF3-9BD760022130Q33581953-C83FAC16-96D2-4943-88FD-3CA3CACF1374Q33613330-86023114-92B3-4F9C-BCC7-F5EA329247D6Q33862990-5E98BF19-76CE-4ABD-83ED-8CAEF645CBF0Q34531661-73A7E624-F12E-4E89-A8A0-20B07DF7E821Q34627512-AB94E863-2223-4D53-9EEA-EF9D7032F2CEQ34734555-902B272A-4B63-4087-864C-E0CCCFB18094Q35114156-5CBBFE9F-1852-4A66-8E1C-8C6ABBAC7015Q35533422-69E467CF-7C5D-4342-80BC-FF6FEFD12F72Q35582682-514BAEBB-A974-4F72-A7D3-F3D5AE92EB38Q35911451-5F2F18C0-6BE5-4229-B34B-FD5005D3C312Q36312374-6A446A25-2C78-4050-A026-BC74331C7C9FQ36754807-08C1DF11-2312-4F80-9CF9-FA9759D91CACQ37109719-7369DA8C-6AD2-4B0C-AB1F-512CE252360EQ37568540-24425EA6-6F59-46AF-8070-94492D3177B7Q38325679-83EB81C3-6F13-46A4-ADC1-E0DF001005A6Q41769678-D4568E7B-2462-4EEC-A6F5-9D162C8DB257Q42176712-FC2AB997-848C-4768-9F37-D56B0DB728C9Q46294638-30541B0A-D023-4FA9-8179-17AE5F3047D9Q46425509-4169DE86-413F-4B3C-8356-57B8C7F8CF8BQ46945650-816E35FE-4CDB-4E1B-841F-A0B0537480A1Q47303561-D380FAB5-4297-4F68-AE87-1F852987AABEQ51480098-723A97B2-F5A9-4B61-8FC1-4E2FE7F56DD4Q52876599-6089A33A-1C55-4885-B39C-0CF31BCD47E1Q53009256-FB4934E2-11A4-40F2-BDAC-E7425B4D0EB5
P2860
Molecular mechanism of recombinant liver fatty acid binding protein's antioxidant activity.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 27 May 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Molecular mechanism of recombi ...... rotein's antioxidant activity.
@en
Molecular mechanism of recombi ...... rotein's antioxidant activity.
@nl
type
label
Molecular mechanism of recombi ...... rotein's antioxidant activity.
@en
Molecular mechanism of recombi ...... rotein's antioxidant activity.
@nl
prefLabel
Molecular mechanism of recombi ...... rotein's antioxidant activity.
@en
Molecular mechanism of recombi ...... rotein's antioxidant activity.
@nl
P2093
P2860
P50
P1476
Molecular mechanism of recombi ...... protein's antioxidant activity
@en
P2093
P2860
P304
P356
10.1194/JLR.M900177-JLR200
P577
2009-05-27T00:00:00Z